Chronic Kidney Disease and Arterial Stiffness: A Two-Way Path

Felipe Inserra1,2, Pedro Forcada2,3, Agustina Castellaro4

  • 1Advisor of Academic Vice-Rectory Department, Maimonides University, Buenos Aires, Argentina.

Frontiers in Medicine
|December 10, 2021
PubMed

Insights

Chronic kidney disease (CKD) accelerates arterial stiffening through inflammation and oxidative stress, impacting heart function and tissue perfusion. This highlights the critical two-way relationship between renal dysfunction and cardiovascular health.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Pathophysiology

Background:

  • The interplay between kidney and heart health is complex and significantly influences overall well-being.
  • Chronic kidney disease (CKD) induces vascular structural and functional changes with notable hemodynamic consequences.

Purpose of the Study:

  • To elucidate the pathophysiological mechanisms linking arterial stiffness and renal dysfunction.
  • To provide a comprehensive understanding of the bidirectional relationship between the kidneys and the heart.

Main Methods:

  • Review of existing literature on the pathophysiology of CKD and its cardiovascular implications.
  • Analysis of the mechanisms driving arterial stiffening in CKD patients.

Main Results:

  • CKD promotes early arterial stiffening via oxidative stress and inflammation, impairing left ventricular function and tissue perfusion.
  • Vascular endothelium dysfunction, increased vascular tone, wall thickening, and arterial calcification are key consequences of CKD.
  • Autonomic and hormonal imbalances in CKD exacerbate inflammation and fibrosis, contributing to arterial lesions.

Conclusions:

  • Arterial stiffening and volume overload in CKD lead to increased left ventricular afterload, remodeling, hypertrophy, and heart failure.
  • Reduced renal mass and compensatory hyperfiltration are associated with arterial stiffness and cardiovascular events.
  • Understanding these pathophysiological processes is crucial for managing the cardiovascular impact of renal dysfunction.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
134
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
143
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
104
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
141
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
65
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
85